{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T18:07:33Z","timestamp":1776362853450,"version":"3.51.2"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T00:00:00Z","timestamp":1341532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0040509","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T21:02:25Z","timestamp":1341608545000},"page":"e40509","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Systemic Administration of Tripeptidyl Peptidase I in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis: Effect of Glycan Modification"],"prefix":"10.1371","volume":"7","author":[{"given":"Yu","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Sohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Sleat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,7,6]]},"reference":[{"key":"ref1","first-page":"131","article-title":"Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I. FEBS Lett","volume":"443","author":"DJ Vines","year":"1999"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis.","volume":"277","author":"DE Sleat","year":"1997","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme replacement for lysosomal diseases.","volume":"57","author":"RO Brady","year":"2006","journal-title":"Annu Rev Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/B:BOLI.0000031101.12838.c6","article-title":"Enzyme replacement and enhancement therapies for lysosomal diseases.","volume":"27","author":"RJ Desnick","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/mt.2011.130","article-title":"Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis.","volume":"19","author":"S Xu","year":"2011","journal-title":"Mol Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ymgme.2009.10.002","article-title":"Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen.","volume":"99","author":"D Auclair","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid.","volume":"91","author":"P Dickson","year":"2007","journal-title":"Mol Genet Metab"},{"key":"ref8","first-page":"115","article-title":"Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I. Mol Genet Metab","volume":"101","author":"PI Dickson","year":"2010"},{"key":"ref9","first-page":"60ra89","article-title":"Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I. Sci Transl Med","volume":"2","author":"AD Dierenfeld","year":"2010"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.gt.3300931","article-title":"Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector.","volume":"6","author":"SS Elliger","year":"1999","journal-title":"Gene Ther"},{"key":"ref11","first-page":"163","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I. Mol Genet Metab","volume":"83","author":"E Kakkis","year":"2004"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.expneurol.2011.06.019","article-title":"Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion.","volume":"231","author":"RJ Ziegler","year":"2011","journal-title":"Exp Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis.","volume":"16","author":"M Chang","year":"2008","journal-title":"Mol Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ana.22262","article-title":"Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis.","volume":"69","author":"D Tsuji","year":"2011","journal-title":"Ann Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.expneurol.2008.10.021","article-title":"Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease.","volume":"215","author":"JC Dodge","year":"2009","journal-title":"Exp Neurol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1203\/01.PDR.0000129661.40499.12","article-title":"Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice.","volume":"56","author":"BL Gliddon","year":"2004","journal-title":"Pediatr Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1203\/00006450-199906000-00010","article-title":"Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.","volume":"45","author":"C Vogler","year":"1999","journal-title":"Pediatr Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1073\/pnas.0405042101","article-title":"Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier.","volume":"101","author":"A Urayama","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/mt.2008.84","article-title":"Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the newborn mouse.","volume":"16","author":"A Urayama","year":"2008","journal-title":"Mol Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/hmg\/ddn237","article-title":"Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice.","volume":"17","author":"J Blanz","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII.","volume":"102","author":"C Vogler","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1073\/pnas.0712147105","article-title":"Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII.","volume":"105","author":"JH Grubb","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"16441","DOI":"10.1074\/jbc.270.27.16441","article-title":"Soluble insulin-like growth factor II\/mannose 6-phosphate receptor carries multiple high molecular weight forms of insulin-like growth factor II in fetal bovine serum.","volume":"270","author":"KJ Valenzano","year":"1995","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1074\/jbc.M008562200","article-title":"The human CLN2 protein\/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH.","volume":"276","author":"L Lin","year":"2001","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1074\/jbc.M806943200","article-title":"Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis.","volume":"284","author":"J Guhaniyogi","year":"2009","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.1021\/bi9517704","article-title":"Influence of the carbohydrate moiety on the stability of glycoproteins.","volume":"35","author":"C Wang","year":"1996","journal-title":"Biochemistry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jcb.240360207","article-title":"Heparanases and tumor metastasis.","volume":"36","author":"M Nakajima","year":"1988","journal-title":"J Cell Biochem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.expneurol.2011.04.004","article-title":"Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA.","volume":"230","author":"T Rozaklis","year":"2011","journal-title":"Exp Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","article-title":"A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration.","volume":"24","author":"DE Sleat","year":"2004","journal-title":"J Neurosci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/bj3570049","article-title":"Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis.","volume":"357","author":"L Lin","year":"2001","journal-title":"Biochem J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/abio.1993.1096","article-title":"An assay to detect glycoproteins that contain mannose 6-phosphate.","volume":"209","author":"KJ Valenzano","year":"1993","journal-title":"Analytical biochemistry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/clinchem\/46.7.1005","article-title":"Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatin-insensitive protease assays.","volume":"46","author":"I Sohar","year":"2000","journal-title":"Clin Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ymgme.2008.01.014","article-title":"Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis.","volume":"94","author":"DE Sleat","year":"2008","journal-title":"Mol Genet Metab"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0040509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T10:55:00Z","timestamp":1594378500000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0040509"}},"subtitle":[],"editor":[{"given":"Raphael","family":"Schiffmann","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,6]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0040509","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,6]]}}}